Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Jul 11, 2016 $0.560 $0.600 $0.530 $5.80 9 700
Jul 08, 2016 $0.550 $0.620 $0.540 $5.70 11 700
Jul 07, 2016 $0.570 $0.590 $0.530 $5.40 10 700
Jul 06, 2016 $0.630 $0.630 $0.560 $5.60 17 700
Jul 05, 2016 $0.650 $0.650 $0.620 $6.30 15 800
Jul 01, 2016 $0.610 $0.650 $0.580 $6.30 24 100
Jun 30, 2016 $0.530 $0.650 $0.530 $5.90 77 600
Jun 29, 2016 $0.510 $0.530 $0.510 $5.10 6 200
Jun 28, 2016 $0.530 $0.530 $0.500 $5.00 10 700
Jun 27, 2016 $0.540 $0.590 $0.490 $5.00 11 700
Jun 24, 2016 $0.490 $0.630 $0.450 $5.50 61 000
Jun 23, 2016 $0.540 $0.560 $0.520 $5.30 15 100
Jun 22, 2016 $0.500 $0.530 $0.450 $5.20 18 100
Jun 21, 2016 $0.500 $0.540 $0.480 $4.90 11 600
Jun 20, 2016 $0.520 $0.540 $0.450 $4.90 7 500
Jun 17, 2016 $0.500 $0.550 $0.500 $5.00 11 600
Jun 16, 2016 $5.25 $5.50 $5.00 $5.02 13 854
Jun 15, 2016 $5.14 $5.52 $5.14 $5.14 11 480
Jun 14, 2016 $5.40 $5.50 $5.30 $5.30 5 590
Jun 13, 2016 $5.30 $5.60 $5.30 $5.30 3 080
Jun 10, 2016 $5.30 $5.60 $5.30 $5.30 9 742
Jun 09, 2016 $5.40 $5.50 $5.31 $5.31 11 274
Jun 08, 2016 $5.45 $5.60 $5.35 $5.45 9 637
Jun 07, 2016 $5.50 $5.60 $5.30 $5.40 10 920
Jun 06, 2016 $5.42 $5.50 $5.40 $5.42 8 544
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT